IMCC - IM Cannabis Corp


0.2997
-0.044   -14.715%

Share volume: 3,084,623
Last Updated: 04-23-2026
Pharmaceutical Products/Medicinal Chemicals: -0.10%

PREVIOUS CLOSE
CHG
CHG%

$0.34
-0.04
-0.13%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
93%
Profitability 100%
Dept financing 50%
Liquidity 75%
Performance 100%
Performance
5 Days
-26.88%
1 Month
-50.02%
3 Months
-78.12%
6 Months
-79.89%
1 Year
-80.41%
2 Year
-85.66%
Key data
Stock price
$0.30
P/E Ratio 
N/A
DAY RANGE
$0.28 - $0.34
EPS 
N/A
52 WEEK RANGE
$0.28 - $7.12
52 WEEK CHANGE
-$78.89
MARKET CAP 
0.000
YIELD 
N/A
SHARES OUTSTANDING 
0.000
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-07-2025
BETA 
0.00
PUBLIC FLOAT 
N/A
AVERAGE 10 VOLUME 
$1,424,049
AVERAGE 30 VOLUME 
$1,001,844
Company detail
CEO: Oren Shuster
Region: US
Website: imcannabis.com
Employees: 340
IPO year: 2021
Issue type:
Market: XNAS
Industry: Pharmaceutical Products/Medicinal Chemicals
Sector: Manufacturing

IM Cannabis Corp. engages in breeding, growing, and supply medical cannabis products. It offers cannabis flowers and strain specific cannabis extracts under the IMC brand; dried flower, pre-rolls, and pressed hash offerings under the WAGNERS and Highland Grow brands. The company serves medical patients and adult-use recreational consumers.

Recent news